Success Rates
Individualized patient care and personalized treatment plans are essential to successful fertility treatments. This approach, in combination with our emphasis on single embryo transfer, leads to extraordinary success rates. ART Fertility Clinics has consistently been one of the most successful clinics in the Middle East and India, with a high live birth rate compared to other clinics.
Success Rate Globally
Ongoing Pregnancy Rates for the Year 2017-2023*.
2017
Overall Pregnancy Rate: 69%
Ongoing Pregnancy Rate: 58%

2018
Overall Pregnancy Rate: 69%
Ongoing Pregnancy Rate: 58%

2019
Overall Pregnancy Rate: 69%
Ongoing Pregnancy Rate: 58%

2020
Overall Pregnancy Rate: 69%
Ongoing Pregnancy Rate: 58%

2021
Overall Pregnancy Rate: 70%
Ongoing Pregnancy Rate: 58%

2022
Overall Pregnancy Rate: 69%
Ongoing Pregnancy Rate: 58%

2023
Overall Pregnancy Rate: 69%
Ongoing Pregnancy Rate: 58%

*Last updated on July 15, 2024
- Frozen Embryo Transfer with Pre-Implantation Genetic Testing for Aneuploidies (PGT-A)
- Pregnant Rate Is the Positive Pregnancy Test (Pregnancy Hormone in the Blood).
- Ongoing Pregnancy Rate or Clinical Pregnancy Is a Pregnancy with a Positive Heartbeat (Baby With a Positive Heartbeat in the Scan).
Book an Appointment with Our IVF Experts
ART Fertility Clinics has consistently been one of the most successful clinics in the Middle East and India, with a high live birth rate compared to other clinics. The clinic has a focus on individualized patient care and personalized treatment plans, which leads to high success rates. The overall pregnancy rate for 2021 was 70% and the ongoing pregnancy rate was 58%. The success rates from 2017 to 2020 varied from 69-78% for the overall pregnancy rate and 52-65% for the ongoing pregnancy rate. The higher incidence of infertility in the GCC is due to cultural and social factors such as consanguinity, vitamin D deficiency, obesity, and cultural factors like having large families at an older age. These factors can lead to issues such as reduced ovarian reserve, chromosomal abnormalities, menstrual irregularities, and reduced response to IVF treatments.







